Treatment of polyarthritis by immunosuppressive agents
Frei, P.C.
Schweizerische Medizinische Wochenschrift 103(33): 1159-1161
1973
ISSN/ISBN: 0036-7672 PMID: 4751558 Document Number: 60899
Document emailed within 1 workday
Related Documents
Vignon, G.; Bied, J.C. 1971: Comparison of various immunosuppressive agents in the treatment of rheumatoid polyarthritis. 41 personal cases Revue du Rhumatisme et des Maladies Osteo-Articulaires 38(12): 785-795Borberg, H.; Kindler, J.; Mahieu, B.; Sladecek, I.; Tschöpe, W.; Sieberth, H.G.; Gross, R. 1978: Treatment of the Goodpasture syndrome. Successful combination of plasma exchange and treatment with immunosuppressive agents Die Medizinische Welt 29(13): 545-547
Kamińska, M.; Piotrowicz, E.; Ratajczak, B.; Boj, E. 1973: Treatment of idiopathic pulmonary hemosiderosis with immunosuppressive agents Pediatria Polska 48(6): 765-769
Schuppli, R. 1970: Treatment of dermatologic lesions using immunosuppressive agents and cytostatics Münchener Medizinische Wochenschrift 112(12): 526-530
Skłodowski, P. 1993: Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents Neurologia i Neurochirurgia Polska 27(6): 877-883
Carreira Delgado, P.E.; Gómez-Reino Carnota, J.J.; Morillas López, L.; Ibero Díaz, I.; Mateo Bernardo, I. 1986: Effectiveness and safety of immunosuppressive agents in the treatment of rheumatoid arthritis Medicina Clinica 86(14): 575-578
Viozzi, A.; Gasparini, G.; Cagliari, P. 1970: Preliminary clinical experiences with immunosuppressive agents in prenatal treatment of Rh isoimmunization Minerva Ginecologica 22(9): 462-463
Couchoud, C.; Laville, M.; Boissel, J.P. 1994: Treatment of extra-membranous glomerulonephritis with immunosuppressive agents or difficulties of meta-analysis in nephrology Therapie 49(3): 171-173
Ricken, D.; Marsteller, H.J.; Baack, G. 1971: Immunosuppressive therapy of primary chronic polyarthritis and systemic lupus erythematodes disseminatus Die Medizinische Welt 39: 1501-1506
Slavin, S. 1993: Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT Bone Marrow Transplantation 12(1): 85-88
Mertens, H.G. 1980: Immunosuppressive agents Die Medizinische Welt 31(40): 1440-1443
Sanchez-Fayos, J.; Outeirino, J.; Serrano, J.; Calabuig, M.T.; Paniagua, G. 1970: Immunosuppressive agents in hematology Minerva Medica 61(55): 3082-3098
Genazzani, E.; Periti, P. 1978: Pharmacology of immunosuppressive agents Minerva Medica 69(38): 2587-2604
Treleaven, J.G.; Barrett, A.J. 1990: Immunosuppressive agents in current use British Journal of Hospital Medicine 43(4): 256-264
Bach, J.F.; Fournier, C. 1972: Definition and evaluation of immunosuppressive agents La Nouvelle Presse Medicale 1(35): 2289-2291
Rogner, G. 1974: Thrombocyte function during the use of immunosuppressive agents Folia Haematologica 101(5): 792-799
Nishi, S. 2011: Immunosuppressive agents in kidney transplantation Nihon Jinzo Gakkai Shi 53(1): 1-5
Frey, B.M. 1993: Mechanism of action of immunosuppressive agents Therapeutische Umschau. Revue Therapeutique 50(2): 71-76
Calne, R. 1994: Criteria and assessment of immunosuppressive agents Transplantation Proceedings 26(6): 3279
Ward, M.; Lazda, V.A.; Gaddis, P.J.; Stormoen, B.M.; Smith, Y.; Fabrega, A.J.; Pollak, R. 1993: In vitro response to immunosuppressive agents in blacks Transplantation Proceedings 25(4): 2470-2471